// App-Quantinova.ai

Sa1246 : In IBD Outpatients Knowledge of Fecal Calprotectin and Infliximab Trough Levels Significantly Alters Clinical Decision Making

Researchers

Presenter

  • Karen I. Kroeker

Principal Investigators

  • Haili Wang

  • Connie Prosser

  • Shalapay Carol

  • Neil Dhami

  • Darryl K. Fedorak

  • Richard N. Fedorak

Medical Centers

  • University of Alberta, Edmonton, AB, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

  • Infectious Diseases (ID)

  • Genetic Disorder

Disease

  • Inflammatory bowel disease

Biomarkers

  • Faecal calprotectin

Drug/Treatment

  • Infliximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved